epirubicin has been researched along with Skin Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bartsch, R; Deutschmann, C; Hacker, S; Haslik, W; Kornauth, C; Mader, RM; Nedomansky, J; Pluschnig, U; Steger, GG | 1 |
| Bernard-Marty, C; Dalenc, F; de Lafontan, B; Dulguerova, P; Guerrero, D; Guyonnaud, J; Levasseur, N; Levecq, JM; Massabeau, C; Ranc Royo, AL; Ribet, V; Rossi, AB; Salas, S; Sarda, C; Sibaud, V | 1 |
| Ardavanis, A; Basioukas, S; Orphanos, G; Rigatos, G; Skafida, S | 1 |
| Durmus, C; Heitmann, C; Ingianni, G | 1 |
| Holmes, JD; Khan, MS | 1 |
| Bacoyiannis, C; Karabellis, A; Karagiaouris, P; Karvounis, N; Komitsopoulou, P; Mylonakis, N; Papanicolaou, V; Tsavaris, NB; Tzannou, I; Zoannou, A | 1 |
1 trial(s) available for epirubicin and Skin Diseases
| Article | Year |
|---|---|
Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Emollients; Epirubicin; Female; Fluorouracil; Gonadotropin-Releasing Hormone; Hand-Foot Syndrome; Humans; Hydrotherapy; Hyperpigmentation; Lymphedema; Manual Lymphatic Drainage; Massage; Mastectomy; Middle Aged; Neoadjuvant Therapy; Pruritus; Quality of Life; Radiodermatitis; Radiotherapy, Adjuvant; Skin Care; Skin Diseases; Tamoxifen; Taxoids | 2018 |
5 other study(ies) available for epirubicin and Skin Diseases
| Article | Year |
|---|---|
Tissue distribution of epirubicin after severe extravasation in humans.
Topics: Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cytokines; Doxorubicin; Epirubicin; Female; Humans; Inflammation; Male; Middle Aged; Necrosis; Skin Diseases; Surgical Flaps; Tissue Distribution; Wound Healing | 2021 |
Coincidential successful treatment of Jessner-Kanof disease with chemotherapy.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphocytes; Mastectomy, Radical; Recurrence; Skin Diseases; Time Factors; Treatment Outcome | 2008 |
Surgical management after doxorubicin and epirubicin extravasation.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Debridement; Dermatologic Surgical Procedures; Doxorubicin; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Injections, Intravenous; Male; Middle Aged; Necrosis; Skin; Skin Diseases; Skin Transplantation; Skin Ulcer | 1998 |
Reducing the morbidity from extravasation injuries.
Topics: Adult; Aged; Clinical Protocols; Doxorubicin; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Forearm; Hand; Humans; Infusions, Intravenous; Male; Middle Aged; Skin Diseases | 2002 |
Conservative approach to the treatment of chemotherapy-induced extravasation.
Topics: Adult; Aged; Antineoplastic Agents; Betamethasone; Doxorubicin; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycins; Mitoxantrone; Skin Diseases; Vinblastine | 1990 |